However, albuminuria is a potent predictor of eGFR decline, so these drugs could delay progression in DKD by reducing albuminuria.99 In a subgroup analysis of the LEADER trial the effect of liraglutide vs
This work was also supported by Key R&D Program of Anhui Province (to SX), Program for Innovative Research Team of The First Affiliated Hospital of USTC (to JW), Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131], China International Medical Foundation (to XZ), Natural Science Foundation of Anhui Province [Grant No
GLP 1 agonists exhibit their efficacy through significant improvements in both fasting and mealtime glucose readings, underpinning their pivotal status for glycemic regulationa cornerstone in diabetes management strategies
Retatrutide is a triple agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, whereas semaglutide targets only GLP-1 and tirzepatide targets GLP-1 and GIP